Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03202641 · ClinicalTrials.gov registry record · NA
Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03202641: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT03202641 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03202641, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The goal of this interventional crossover study, in intubated and mechanically ventilated Acute Respiratory Distress Syndrome (ARDS) patients, is to compare two positive end-expiratory pressure (PEEP) titration techniques regarding: respiratory mechanics, gas exchange, changes in aeration, ventilation/perfusion matching its impact on cardiac function, especially the right heart (RH). The PEEP titration techniques are: PEEP selection based on low PEEP/high FiO2 table ("PEEPARDSnet") and lung recruitment maneuver (LRM) plus PEEPdec titration based on the best compliance of the respiratory system("PEEPLRM").
Interventions
- PROCEDURE PEEP ARDSnet
- PROCEDURE PEEP LRM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-06-19 |
| Est. Completion | 2020-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03202641
The ClinicalTrials.gov registry entry for NCT03202641 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PEEP ARDSnet is the first listed.
NCT03202641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03202641 about?
NCT03202641 is a clinical study titled "Open Lung Strategy, Gas Distribution and Right Heart Function in ARDS Patients". The goal of this interventional crossover study, in intubated and mechanically ventilated Acute Respiratory Distress Syndrome (ARDS) patients, is to compare two positive end-expiratory pressure (PEEP) titration techniques regarding: respiratory mechanics, gas exchange, changes in aeration, ventilati...
What is the current status of trial NCT03202641?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-06-19. Estimated completion is 2020-05-12.
What interventions are being tested in trial NCT03202641?
The interventions under investigation include: PEEP ARDSnet (PROCEDURE), PEEP LRM (PROCEDURE).
Who is sponsoring clinical trial NCT03202641?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.